Not Signed In -
Smoking |
Nicotine |
Clinical Trial: A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to evaluate the safety and tolerability of an investigational drug that may help individuals to stop smoking.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Smoking | | Phase II Phase III |
MedlinePlus related topics: Smoking
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Smoking greater than/equal to 10 cigarettes/day for at least 1 year
- Laboratory tests that meet the criteria of the study
- In overall good health as determined by the investigator
Exclusion Criteria:
- Psychiatric diagnoses
- Certain cancers
- Patients who use nicotine replacement therapy
- Patients on a diet regimen
More Information
Study ID Numbers: 2005_012
Record last reviewed: April 2005
Last Updated: April 22, 2005
Record first received: April 22, 2005
ClinicalTrials.gov Identifier: NCT00109135
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-05-03
Record last reviewed: April 2005
Last Updated: April 22, 2005
Record first received: April 22, 2005
ClinicalTrials.gov Identifier: NCT00109135
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-05-03
Source: ClinicalTrials.gov
Cache Date: May 4, 2005
Resources
- (National Women's Health Information Center, OWH, HHS)
- ABC's of Tobacco (National Center for Tobacco Free Kids)
email this page
print this page
bookmark this page
feedback on this page
